| 标题 |
737MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic colorectal cancer (mCRC): Final analysis of DESTINY-CRC02, a randomized, phase II trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:K. Raghav; S. Siena; A. Takashima; K. Kato; M. van den Eynde; et al 出版日期:2025-11-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)